Share on StockTwits

Shares of Neuralstem (NYSE:CUR) were the recipient of a significant growth in short interest during the month of July. As of July 31st, there was short interest totalling 9,983,880 shares, a growth of 3.9% from the July 15th total of 9,611,785 shares, reports. Currently, 12.0% of the shares of the stock are short sold. Based on an average daily volume of 702,872 shares, the short-interest ratio is currently 14.2 days.

CUR has been the subject of a number of recent research reports. Analysts at Aegis reiterated a “buy” rating on shares of Neuralstem in a research note on Friday.

Shares of Neuralstem (NYSE:CUR) traded up 3.33% on Monday, hitting $3.41. The stock had a trading volume of 469,770 shares. Neuralstem has a 1-year low of $1.43 and a 1-year high of $4.81. The stock’s 50-day moving average is $3.48 and its 200-day moving average is $3.72. The company’s market cap is $295.9 million.

Neuralstem (NYSE:CUR) last posted its quarterly earnings results on Friday, August 8th. The company reported ($0.08) EPS for the quarter, missing the Thomson Reuters consensus estimate of ($0.05) by $0.03. Analysts expect that Neuralstem will post $-0.25 EPS for the current fiscal year.

Neuralstem, Inc is a development-stage company focused on the development and commercialization of treatments for central nervous system disease based on transplanting human neural stems cells and the use of small molecule drugs.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.